share_log
Reuters ·  13:30
Merck & Co Inc - Patients in Keyform-008 Trial May Continue Therapy Until Study Completion
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment